Collectively, these data indicate that the CD44/CD24 marker combination does not enable consistent identification of a unique population of highly tumorigenic cells in salivary gland mucoepidermoid carcinomas. The gene discussed is CD24; the disease is salivary gland mucoepidermoid carcinoma.